Explore more publications!

The Latin American Examiner: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Latin American Examiner.

Press releases published on November 4, 2025

Erdene Announces Q3 2025 Results Provides Bayan Khundii Mining and Exploration Update
Entrée Resources Announces Third Quarter 2025 Results
Tenaya Therapeutics Announces New Clinical Data for TN-201 Gene Therapy will be Featured in Late-Breaking Presentation at the American Heart Association Scientific Sessions 2025
Lili Latin Dance Hosts Dance Social to Celebrate Culture, Connection, and Community Support for Local Families
Imperial Reports Third Quarter 2025 Financial Results
Ero Copper Reports Third Quarter 2025 Operating and Financial Results
Wesdome Reports Strong Third Quarter 2025 Financial Results
California Resources Corporation Reports Third Quarter 2025 Financial and Operating Results
California Resources Corporation and Capital Power to Explore Decarbonized Power Solutions in California
Sana Biotechnology to Present at the TD Cowen Immunology & Inflammation Summit
Revolution Medicines to Participate in November 2025 Investor Conferences
Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update on November 13, 2025
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2025 Financial Results
Supernus Announces Third Quarter 2025 Financial Results
Acumen Pharmaceuticals to Participate in the Stifel Healthcare Conference
Lisata Therapeutics Highlights Positive Preclinical Data of Certepetide as Part of Antibody-Drug Conjugate Combinations as Reported by Licensing Partner Catalent

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions